Stockscreener 앱 받기
12.85
10.89%
-1.57
시간 외 거래:
12.30
-0.55
-4.28%
전일 마감가:
$14.42
열려 있는:
$14.49
하루 거래량:
347.20K
Relative Volume:
3.00
시가총액:
$601.94M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+86.23%
1개월 성능:
+131.95%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$12.15
$15.00
1주일 범위
$6.7327
$15.37
52주 변동 폭
$3.4341
$15.37
Capsovision Inc Stock (CV) Company Profile
명칭
Capsovision Inc
전화
(408) 370-4790
주소
18805 COX AVENUE SUITE 250, SARATOGA
CV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
12.85 | 675.48M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-28 | 개시 | Roth Capital | Buy |
| 2025-07-28 | 개시 | The Benchmark Company | Speculative Buy |
Capsovision Inc 주식(CV)의 최신 뉴스
CapsoVision (NASDAQ: CV) Stock Rockets After-Hours: Price Action, Q3 Earnings and 2026 Outlook - ts2.tech
Oxford Industries, Ur-Energy, Oracle And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Is CapsoVision Showing How Far A Single Capsule Can Take A Med-Tech Company? - RTTNews
What Sparked CapsoVision's (CV) 53% Surge In After-Hours Trading? - Benzinga
A look into CapsoVision Inc (CV)’s deeper side - setenews.com
CapsoVision Welcomes David Garcia to its Senior Executive Team - Medical Product Outsourcing
CapsoVision (CV) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
CapsoVision reports Q3 EPS (17c) vs ($2.79) last year - MSN
CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor Conference - GlobeNewswire
CapsoVision (NASDAQ: CV) to Host 1:1 Investor Meetings at Benchmark Discovery Conference - Stock Titan
CapsoVision, Inc.Common Stock (NQ: CV - FinancialContent
FY2028 EPS Estimates for CapsoVision Cut by Roth Capital - MarketBeat
CapsoVision (CV) Price Target Increased by 20.00% to 6.12 - Nasdaq
CapsoVision CFO Kevin Lundquist Steps Down - MSN
David Michael Garcia Net Worth (2025) - GuruFocus
Benchmark reiterates Speculative Buy rating on CapsoVision stock at $5 By Investing.com - Investing.com Australia
Benchmark reiterates Speculative Buy rating on CapsoVision stock at $5 - Investing.com
CapsoVision Reports Revenue Growth and Strategic Advances - TipRanks
CapsoVision Q3 2025 Earnings Call Transcript - MarketBeat
CapsoVision, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
CapsoVision, Inc. (CV) Q3 FY2025 earnings call transcript - Yahoo Finance
[8-K] CapsoVision, Inc Reports Material Event | CV SEC FilingForm 8-K - Stock Titan
CapsoVision Reports Third Quarter 2025 Financial Results - GlobeNewswire
CapsoVision Inc (CV) Q3 2025 Earnings Report Preview: What to Ex - GuruFocus
CapsoVision Inc (CV) Q3 2025 Earnings Report Preview: What to Expect - Yahoo Finance
CapsoVision CFO Lundquist steps down - MSN
CapsoVision Seeks FDA Breakthrough Status for CapsoCam - MSN
CapsoVision seeks FDA breakthrough status for pancreatic cancer tool By Investing.com - Investing.com Nigeria
CapsoVision Submits Breakthrough Device Designation Application to FDA for Pancreatic Cancer Screening Capsule - The Manila Times
CapsoVision seeks FDA breakthrough status for pancreatic cancer tool - Investing.com
Q3 Earnings Forecast for CapsoVision Issued By Roth Capital - MarketBeat
CapsoVision (NASDAQ:CV) and Bioventus (NASDAQ:BVS) Financial Contrast - Defense World
Roth Capital Upgrades CapsoVision (NASDAQ:CV) to Strong-Buy - Defense World
United States Smart Pills Market to hit US$ 619.10 Million by 2033 - openPR.com
CapsoVision appoints David Garcia as SVP of finance By Investing.com - Investing.com Australia
[Form 3] CapsoVision, Inc Initial Statement of Beneficial Ownership - Stock Titan
[Form 4] CapsoVision, Inc Insider Trading Activity - Stock Titan
Capsovision, Inc. Appoints David Garcia as Senior Vice President of Finance and Principal Accounting Officer, Effective November 3, 2025 - MarketScreener
CapsoVision Appoints David Garcia as Finance VP - TipRanks
CapsoVision appoints David Garcia as SVP of finance - Investing.com
CapsoVision Appoints David Garcia as Senior Vice President of Finance - The Manila Times
CapsoVision Appoints New Principal Financial Officer - TradingView
CapsoVision, Inc. Appoints David Garcia as Principal Financial Officer, Effective from November 3, 2025 - MarketScreener
CapsoVision (NASDAQ: CV) names David Garcia SVP of Finance; ex-Matterport FP&A VP - Stock Titan
CapsoVision to Release Third Quarter 2025 Financial Results on Thursday, November 13, 2025 - The Manila Times
CapsoVision (NASDAQ:CV) & Bioventus (NASDAQ:BVS) Critical Review - Defense World
Weiss Ratings Reaffirms "Sell (E-)" Rating for CapsoVision (NASDAQ:CV) - MarketBeat
Capsovision Inc (CV) 재무 분석
Capsovision Inc (CV)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.52%
0.28%
자본화:
|
볼륨(24시간):